123 related articles for article (PubMed ID: 33492858)
1. Cortisol-Producing Adrenal Adenomas With Intense Activity on 68Ga-Pentixafor PET/CT.
Ding J; Tong A; Zhang Y; Zhang H; Huo L
Clin Nucl Med; 2021 Apr; 46(4):350-352. PubMed ID: 33492858
[TBL] [Abstract][Full Text] [Related]
2. Intense 68Ga-Pentixafor Activity in Aldosterone-Producing Adrenal Adenomas.
Ding J; Tong A; Zhang Y; Wen J; Huo L
Clin Nucl Med; 2020 Apr; 45(4):336-339. PubMed ID: 32108693
[TBL] [Abstract][Full Text] [Related]
3. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Heinze B; Fuss CT; Mulatero P; Beuschlein F; Reincke M; Mustafa M; Schirbel A; Deutschbein T; Williams TA; Rhayem Y; Quinkler M; Rayes N; Monticone S; Wild V; Gomez-Sanchez CE; Reis AC; Petersenn S; Wester HJ; Kropf S; Fassnacht M; Lang K; Herrmann K; Buck AK; Bluemel C; Hahner S
Hypertension; 2018 Feb; 71(2):317-325. PubMed ID: 29279316
[TBL] [Abstract][Full Text] [Related]
4. Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68 Ga-Pentixafor PET/CT.
Shu Q; Deng M; Chen Y; Liu N; Cai L
Clin Nucl Med; 2022 Aug; 47(8):e572-e573. PubMed ID: 35426842
[TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using
Ding J; Tong A; Zhang Y; Wen J; Zhang H; Hacker M; Huo L; Li X
J Nucl Med; 2022 Mar; 63(3):368-375. PubMed ID: 34301781
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of 68 Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome.
Ding J; Tong A; Hacker M; Feng M; Huo L; Li X
Clin Nucl Med; 2022 Aug; 47(8):669-676. PubMed ID: 35452014
[TBL] [Abstract][Full Text] [Related]
7. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K; Suzuki S; Igarashi K; Ruike Y; Naito K; Ishida A; Deguchi-Horiuchi H; Fujimoto M; Koide H; Imamura Y; Sakamoto S; Ichikawa T; Ikeda JI; Yokote K
Eur J Endocrinol; 2021 Jun; 185(1):155-165. PubMed ID: 33960957
[TBL] [Abstract][Full Text] [Related]
10. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
Shimizu A; Oriuchi N; Tsushima Y; Higuchi T; Aoki J; Endo K
Ann Nucl Med; 2003 Jul; 17(5):403-6. PubMed ID: 12971640
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
12. The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism.
Zheng Y; Long T; Peng N; Zhen M; Ye Q; Zhang Z; He Y; Chen Z; Gan Y; Luo M; Li C; Liu Z; Guo M; Wang M; Luo X; Hu S; Liu L; Jiang T
J Clin Endocrinol Metab; 2023 Dec; 109(1):171-182. PubMed ID: 37477496
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the diagnostics of aldosterone-producing adrenocortical carcinoma.
Łebek-Szatańska A; Nowak KM; Papierska L
Endokrynol Pol; 2020; 71(6):575-576. PubMed ID: 32944927
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid- and androgen-secreting black adrenocortical adenomas: unique cause of corticotropin-independent Cushing syndrome.
Tanaka S; Tanabe A; Aiba M; Hizuka N; Takano K; Zhang J; Young WF
Endocr Pract; 2011; 17(3):e73-8. PubMed ID: 21700558
[TBL] [Abstract][Full Text] [Related]
15. Abnormal body composition in patients with adrenal adenomas.
Delivanis DA; Hurtado Andrade MD; Cortes T; Athimulam S; Khanna A; Atkinson E; McKenzie T; Takahashi N; Moynagh MR; Bancos I
Eur J Endocrinol; 2021 Oct; 185(5):653-662. PubMed ID: 34406976
[TBL] [Abstract][Full Text] [Related]
16. Androgen- and cortisol-secreting adrenocortical adenoma may also be "subclinical".
Ambrosi B; Costa E; Bonavina L
J Endocrinol Invest; 2008 Apr; 31(4):380-1. PubMed ID: 18475059
[No Abstract] [Full Text] [Related]
17. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
[TBL] [Abstract][Full Text] [Related]
18. Bilateral deoxycorticosterone-secreting adrenocortical adenoma.
Nitta T; Kumamoto Y; Itoh N; Tachiki H; Mikuma N; Tsukamoto T; Iimura O; Shimamoto K
Int J Urol; 1996 Nov; 3(6):494-6. PubMed ID: 9170580
[TBL] [Abstract][Full Text] [Related]
19. Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma.
Baert D; Nobels F; Van Crombrugge P
Acta Clin Belg; 1995; 50(5):310-3. PubMed ID: 8533534
[TBL] [Abstract][Full Text] [Related]
20. Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.
Murayama R; Nishie A; Hida T; Baba S; Inokuchi J; Oda Y; Honda H
Clin Nucl Med; 2019 Dec; 44(12):943-948. PubMed ID: 31490313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
